These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 31550148)
1. Luminescent Gold(I) Complexes of 1-Pyridyl-3-anthracenylchalcone Inducing Apoptosis in Colon Carcinoma Cells and Antivascular Effects. González JJ; Ortega E; Rothemund M; Gold M; Vicente C; de Haro C; Bautista D; Schobert R; Ruiz J Inorg Chem; 2019 Oct; 58(19):12954-12963. PubMed ID: 31550148 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships in cytotoxic Au(I)/Au(III) complexes derived from 2-(2'-pyridyl)benzimidazole. Maiore L; Aragoni MC; Deiana C; Cinellu MA; Isaia F; Lippolis V; Pintus A; Serratrice M; Arca M Inorg Chem; 2014 Apr; 53(8):4068-80. PubMed ID: 24679072 [TBL] [Abstract][Full Text] [Related]
3. A Multitarget Gold(I) Complex Induces Cytotoxicity Related to Aneuploidy in HCT-116 Colorectal Carcinoma Cells. Zhang JJ; Abu El Maaty MA; Hoffmeister H; Schmidt C; Muenzner JK; Schobert R; Wölfl S; Ott I Angew Chem Int Ed Engl; 2020 Sep; 59(38):16795-16800. PubMed ID: 32529715 [TBL] [Abstract][Full Text] [Related]
4. New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status. Altaf M; Monim-Ul-Mehboob M; Kawde AN; Corona G; Larcher R; Ogasawara M; Casagrande N; Celegato M; Borghese C; Siddik ZH; Aldinucci D; Isab AA Oncotarget; 2017 Jan; 8(1):490-505. PubMed ID: 27888799 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2'-pyridyl)benzimidazole as ligand: comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivatives. Serratrice M; Cinellu MA; Maiore L; Pilo M; Zucca A; Gabbiani C; Guerri A; Landini I; Nobili S; Mini E; Messori L Inorg Chem; 2012 Mar; 51(5):3161-71. PubMed ID: 22339487 [TBL] [Abstract][Full Text] [Related]
6. New selective thiolate gold(i) complexes inhibit the proliferation of different human cancer cells and induce apoptosis in primary cultures of mouse colon tumors. Abas E; Pena-Martinez R; Aguirre-Ramírez D; Rodriguez-Dieguez A; Laguna M; Grasa L Dalton Trans; 2020 Feb; 49(6):1915-1927. PubMed ID: 31971194 [TBL] [Abstract][Full Text] [Related]
7. Organogold(III) compounds as experimental anticancer agents: chemical and biological profiles. Massai L; Cirri D; Michelucci E; Bartoli G; Guerri A; Cinellu MA; Cocco F; Gabbiani C; Messori L Biometals; 2016 Oct; 29(5):863-72. PubMed ID: 27476157 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of Gold(I) Complexes Containing Cinnamide: In Vitro Evaluation of Anticancer Activity in 2D and 3D Spheroidal Models of Melanoma and In Vivo Angiogenesis. Ganga Reddy V; Srinivasa Reddy T; Privér SH; Bai Y; Mishra S; Wlodkowic D; Mirzadeh N; Bhargava S Inorg Chem; 2019 May; 58(9):5988-5999. PubMed ID: 30985125 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxic 2',5'-dihydroxychalcones with unexpected antiangiogenic activity. Nam NH; Kim Y; You YJ; Hong DH; Kim HM; Ahn BZ Eur J Med Chem; 2003 Feb; 38(2):179-87. PubMed ID: 12620662 [TBL] [Abstract][Full Text] [Related]
13. Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties. Li CK; Sun RW; Kui SC; Zhu N; Che CM Chemistry; 2006 Jul; 12(20):5253-66. PubMed ID: 16642532 [TBL] [Abstract][Full Text] [Related]
14. Potential of Gold Candidates against Human Colon Cancer. Abbasi M; Yaqoob M; Haque RA; Iqbal MA Mini Rev Med Chem; 2021; 21(1):69-78. PubMed ID: 32767935 [TBL] [Abstract][Full Text] [Related]
15. In vitro anticancer activity of gold(III) complexes with some esters of (S,S)-ethylenediamine-N,N'-di-2-propanoic acid. Pantelić N; Stanojković TP; Zmejkovski BB; Sabo TJ; Kaluđerović GN Eur J Med Chem; 2015 Jan; 90():766-74. PubMed ID: 25528331 [TBL] [Abstract][Full Text] [Related]
16. Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability. Gabbiani C; Casini A; Kelter G; Cocco F; Cinellu MA; Fiebig HH; Messori L Metallomics; 2011 Dec; 3(12):1318-23. PubMed ID: 21887452 [TBL] [Abstract][Full Text] [Related]
17. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure. Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647 [TBL] [Abstract][Full Text] [Related]
18. Exploring the Influence of the Aromaticity on the Anticancer and Antivascular Activities of Organoplatinum(II) Complexes. Zamora A; Pérez SA; Rothemund M; Rodríguez V; Schobert R; Janiak C; Ruiz J Chemistry; 2017 Apr; 23(23):5614-5625. PubMed ID: 28278370 [TBL] [Abstract][Full Text] [Related]
19. Effects of histidin-2-ylidene vs. imidazol-2-ylidene ligands on the anticancer and antivascular activity of complexes of ruthenium, iridium, platinum, and gold. Schmitt F; Donnelly K; Muenzner JK; Rehm T; Novohradsky V; Brabec V; Kasparkova J; Albrecht M; Schobert R; Mueller T J Inorg Biochem; 2016 Oct; 163():221-228. PubMed ID: 27491634 [TBL] [Abstract][Full Text] [Related]
20. Large-bite bis(phosphite) ligand containing mesocyclic thioether moieties: synthesis, reactivity, group 11 (Cu(I), Au(I)) metal complexes and anticancer activity studies on a human cervical cancer (HeLa) cell line. Suresh D; Balakrishna MS; Rathinasamy K; Panda D; Mague JT Dalton Trans; 2008 May; (17):2285-92. PubMed ID: 18414753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]